Cannabis Movers & Shakers: TrueGreen, PSYC, BioSteel Sports Nutrition, Perfect Union, YourWay Cannabis Brands
As we get closer to the Benzinga Cannabis Capital Conference returns (April 20-21) in Miami that will be gathering top…
Are Psychedelics Stocks In Trouble Or Is The Market Reaching Maturity?
Long gone is the heyday of investor enthusiasm and easy access to capital that marked the launch of the psychedelics industry into the public markets.
In recent months, psychedelics stocks entered into a period of turmoil characterized by declining valuations and a generalized capital dry spell.
Psyched: MindCure Shuts Down Operations, Novamind And MindMed Partner For Study
The psychedelics space was shaken up on the news that MindCure Health (OTC:MCURF) was shutting down operations. After a…
Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council
DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the psychedelics space, composed of key thought leaders sharing insights into industry developments, sector trends and breaking news.
Psyched: MindMed’s MDMA Program For Autism, Small Pharma’s New Patent, NovaMentis’ Orphan Drug Designation
The Week In Psychedelics:
MindMed Launches MDMA Program For Social Anxiety And Autism
There Are Now 50 Psychedelics Companies Listed In The U.S. – Here They Are
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors.
Can MDMA (Or Ecstasy) Improve Sexual Desire in Women? MindCure Launches Research Program To Find Out
Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF), a company in the psychedelics space, is looking to bring current advancements in MDMA therapy to women’s sexual dysfunction.